TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa

 

In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an Indian biotech company, has entered into an agreement with Ethiopia's Ministry of Health. This initiative supports Ethiopia's goals under the African Union’s Agenda 2063 and the Partnership for African Vaccine Manufacturing (PAVM), both of which aim to strengthen healthcare systems and build resilience across the continent.

TechInvention will play a crucial role in this groundbreaking initiative by providing comprehensive technical and strategic support throughout the vaccine manufacturing project. This includes updating the feasibility study, developing the design of the manufacturing facility, conducting geotechnical investigations, and assessing environmental and social impacts. The company will also oversee the creation of technical specifications, prepare tender documents for contractor selection, develop bill of quantities, and offer support in product and process technology selection, acquisition, and transfer.

As part of its advisory role, TechInvention will guide the Ethiopian Ministry of Health and other stakeholders on project implementation, ensuring the development of a state-of-the-art vaccine manufacturing facility that adheres to international quality standards.

The official signing ceremony took place on December 26, 2024, in Addis Ababa, with Dr. Mekdes Daba, Minister of Health, Ethiopia, and Syed Ahmed, director and CEO of TechInvention, formalizing the agreement.

In her remarks, Dr. Mekdes Daba highlighted the strategic importance of local vaccine production, stating, "Producing vaccines locally is a key priority for ensuring the health of our population and for pandemic preparedness. This agreement signifies a major step for Ethiopia to produce vaccines locally, meeting not only international quality standards but also positioning Ethiopia as a supplier of vaccines to Africa and beyond. Preparations are already underway to begin construction and manufacturing in the coming months."

Syed Ahmed, director and CEO of TechInvention, expressed his enthusiasm for the partnership, "We are proud to collaborate with the Ministry of Health, Ethiopia, on this transformative initiative. By combining our technical expertise and experience, we are committed to supporting Ethiopia’s vaccine self-reliance and enhancing health security in Africa. This project will be a key step towards ensuring equitable access to vaccines across the continent."

TechInvention remains dedicated to advancing global health equity by empowering low- and middle-income countries (LMICs) to build robust healthcare infrastructures and establish sustainable vaccine manufacturing capabilities. This project represents a major step forward in promoting health security across Africa and contributing to the continent’s long-term pandemic preparedness.

TechInvention is an innovative biotech company that is committed to bringing greater health equity across the world and specially to LMICs. With a ‘One Health’ approach TechInvention has focused on making essential vaccines, diagnostics and biopharmaceuticals acceptable, affordable, and accessible in the developing world.

Techinvention offers expertise in project planning, project feasibility, technology licensing, WHO prequalification (PQ) support, design engineering, regulatory affairs, clinical research, and intellectual property (IP) support to pharmaceutical and biotech companies, governments, and investors, to make a difference to our shared world.